New

Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

›ETF Providers›E Fund Management›03186
03186
HK0001254553
Passive ETFEquity

03186 ETF · E Fund (HK) Solactive Biopharma Select Index ETF

The 03186 Exchange Traded Fund (ETF) is provided by E Fund Management. It is built to track an index: Solactive Biopharma Select Index. The 03186 ETF provides physical exposure, so by buying it you actually own parts of all the underlying holdings. This share class generates a stream of income by distributing dividends.
Real-time data unavailable for 03186
LIVE
CLOSED
Last price
N/A
1M perf.
N/A
1M flows
N/A
AuM
€2.7M
E/R
0.9%
Rating
Not rated
ESG Consensus®
esg grade icon
03186
N/A

Performance & flows

March 24, 2026 → April 1, 2026
00246810%Mar 24Mar 25Mar 26Mar 27Mar 30Mar 31Apr 1
Create a free account to view the flows graph
03186
HK$16.41
+10.24%

Historic performance and flows

1M3M1Y3Y5YMTDQTD
YTD
Perf.N/AN/AN/AN/AN/A
+4.75%
+4.75%
+12.21%
Flows

Key fund info

This ETF's jurisdiction country is not in your region (Europe and Middle East) · 
Main characteristics
Issuer
E Fund Management
ISIN
HK0001254553
AuM
€2.7M
E/R
0.9%
Replication rating
Not rated
ESG Consensus®
esg grade icon
More details
NAV
4/1/2026
HK$16.41
1D NAV change
+4.75%
Dividend policy
Distributing
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
N/A
Inception date
3/23/2026
Jurisdiction
Hong Kong
Distribution
Hong Kong
Legal structure
Open-end Fund
Base currency
HKD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Passive ETF
Benchmark
Solactive Biopharma Select Index
Asset class
Factors
N/A
Investment strategy
The investment objective is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive Biopharma Select Index (the “Index”).
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
See all Trackinsight Enterprise features

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight Enterprise

Advertisement

Risk profile

Historical risk/return profile

Data will be available soon for this fund.
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
Unavailable
100.00%
Sectors
Unavailable
100.00%
Diversification
This fund does not provide direct exposure to underlying securities.
Top 15 holdings
0
This fund does not provide direct exposure to underlying securities
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Replication

Trackinsight replication rating:
Not rated
Replication quality
Calculated over 12m, as of March 31, 2026
Tracking error
Tracking difference
Replication information
Index
Solactive Biopharma Select Index - HKD
Index ticker
SOLG2BTN Index
Index dividend policy
NTR
Replication method
Replication model
More replication analysis are available, exclusively in Trackinsight Enterprise

Issuer

E Fund Management
E Fund Management ID Card
Number of funds
20
Total AuM
€18.05B
Expense ratio range
0.2% - 1.4%
Average expense ratio
0.6675%
View all E Fund Management funds

Frequently asked questions about 03186

What does E Fund (HK) Solactive Biopharma Select Index ETF, 03186, invest in?

03186 is a Passive ETF. This ETF provides exposure to Equally Weighted Biotechnology Equities.

Which benchmark or index does 03186 replicate?

03186 tracks the Solactive Biopharma Select Index - HKD, through a full replication replication method.

What is the Total Expense ratio (TER) of 03186?

03186 carries a total expense ratio (TER) of 0.9%, indicating the annual cost for holding the fund.

When was 03186 launched?

03186 was introduced to the market on March 23, 2026. It trades on Hong Kong

Who is the ETF issuer of 03186?

E Fund (HK) Solactive Biopharma Select Index ETF, 03186, is provided by E Fund Management. Learn more about E Fund Management here.

What is the current assets under management (AUM) of 03186?

03186 oversees €2.7M in assets as of April 1, 2026.

Does 03186 distribute dividends?

03186 follows a distributing dividend policy, meaning it pays out income to investors.

What is the base currency of 03186?

The base currency of 03186 is HKD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
ETF TOOLS
ETF ScreenerCompare ETFsCompare ETF providersPersonal listsETF Portfolio InsightsIndustry data
PLATFORM
Support and feedback
ETF NEWS & RESEARCH
Latest ETF NewsETF Research ReportsGlobal ETF Survey 2025Learn ETF investing
PROFESSIONAL SOLUTIONS
Enterprise SolutionsDue Diligence ServicesETF Data Services
SOLUTIONS FOR
Institutional investorsPrivate banksFinancial advisorsFintech and mediaIndividual investors
CONTACT US
General inquiries
Press and media
Advertising opportunities
Support and feedback
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Get our newsletters
Trackinsight